Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine (Q77879211)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

F Brunel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Darbouret

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Ronco

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

number of pages

12

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

2192-2203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367954%20AND%20SRC:MED&resulttype=core&format=json

Adjuvants for human vaccines--current status, problems and future prospects

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Adjuvants: current status, clinical perspectives and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

The role of helper T cell products in mouse B cell differentiation and isotype regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

T helper cell differentiation in immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Virally induced modulation of murine IgG antibody subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

T- and B-cell recognition of hepatitis B viral antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Cellular recognition and HLA restriction of a midsequence HBsAg peptide in hepatitis B vaccinated individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

A novel cationic liposome reagent for efficient transfection of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Induction of alloreactive cytotoxic T lymphocytes by intra-splenic immunization with allogeneic class I Major Histocompatibility Complex DNA and DC-chol cationic liposomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Prospective study of cellular immunity to hepatitis-B-virus antigens from the early incubation phase of acute hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Improvement of hepatitis B vaccine by the use of a new adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Defect in Th1-like cells of nonresponders to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Altered response of CD4+ T cell subsets to Plasmodium chabaudi chabaudi in B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

TH1 and TH2 T-cell subsets are differentially activated by macrophages and B cells in murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Delineation of contiguous determinants essential for biological functions of the pre-S sequence of the hepatitis B virus envelope protein: its antigenicity, immunogenicity and cell-receptor recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Overcoming class II-linked non-responsiveness to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021

Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900492-7

7 January 2021